Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Jordi Frigola.
European Journal of Medicinal Chemistry | 1989
Jordi Frigola; Augusto Colombo; Juan Pares; Luis Martinez; Rosa Sagarra; Roberto Roser
Abstract 3-Amino-4,5-dihydro-1 H -pyrazoles ( 1–4, 7 ) and related compounds ( 5, 6 ) and some pyrazoles ( 8b–13b ) were prepared. The structures were mainly determined by 13 C NMR spectroscopy. The inhibitory activities on cyclooxygenase, 15-lipoxygenase, thromboxane synthetase and platelet aggregation were assayed. Some compounds are potent inhibitors of 15-lipoxygenase; 4,5-dihydro-3-(1-pyrrolyl)-1-(3-trifluoromethylphenyl)-1 H -pyrazole 7aw was the most potent. 7aw also had a potent inhibitory effect on cyclooxygenase and thromboxane synthetase.3-Amino-4,5-dihydro-1H-pyrazoles (1–4, 7) and related compounds (5, 6) and some pyrazoles (8b–13b) were prepared. The structures were mainly determined by 13C NMR spectroscopy. The inhibitory activities on cyclooxygenase, 15-lipoxygenase, thromboxane synthetase and platelet aggregation were assayed. Some compounds are potent inhibitors of 15-lipoxygenase; 4,5-dihydro-3-(1-pyrrolyl)-1-(3-trifluoromethylphenyl)-1H-pyrazole 7aw was the most potent. 7aw also had a potent inhibitory effect on cyclooxygenase and thromboxane synthetase.
European Journal of Medicinal Chemistry | 1989
Jordi Frigola; Augusto Colombo; Juan Pares; Luis Martinez; Rosa Sagarra; Roberto Roser
Abstract 3-Amino-4,5-dihydro-1 H -pyrazoles ( 1–4, 7 ) and related compounds ( 5, 6 ) and some pyrazoles ( 8b–13b ) were prepared. The structures were mainly determined by 13 C NMR spectroscopy. The inhibitory activities on cyclooxygenase, 15-lipoxygenase, thromboxane synthetase and platelet aggregation were assayed. Some compounds are potent inhibitors of 15-lipoxygenase; 4,5-dihydro-3-(1-pyrrolyl)-1-(3-trifluoromethylphenyl)-1 H -pyrazole 7aw was the most potent. 7aw also had a potent inhibitory effect on cyclooxygenase and thromboxane synthetase.3-Amino-4,5-dihydro-1H-pyrazoles (1–4, 7) and related compounds (5, 6) and some pyrazoles (8b–13b) were prepared. The structures were mainly determined by 13C NMR spectroscopy. The inhibitory activities on cyclooxygenase, 15-lipoxygenase, thromboxane synthetase and platelet aggregation were assayed. Some compounds are potent inhibitors of 15-lipoxygenase; 4,5-dihydro-3-(1-pyrrolyl)-1-(3-trifluoromethylphenyl)-1H-pyrazole 7aw was the most potent. 7aw also had a potent inhibitory effect on cyclooxygenase and thromboxane synthetase.
Journal of Medicinal Chemistry | 1993
Jordi Frigola; Juan Pares; Jordi Corbera; David Vano; Ramon Mercè; Antoni Torrens; Josep Mas; Eduard Valenti
Journal of Medicinal Chemistry | 1994
Jordi Frigola; Antoni Torrens; José Aurelio Castrillo; Josep Mas; David Vano; Berrocal Jm; Calvet C; Salgado L; Redondo J; García-Granda S
Archive | 1988
Augusto Colombo; Juan Pares; Jordi Frigola
Journal of Medicinal Chemistry | 1995
Jordi Frigola; David Vano; Antoni Torrens; Angels Gomez-Gomar; Edmundo Ortega; Santiago García-Granda
Chirality | 1999
Antoni Torrens; José Aurelio Castrillo; Jordi Frigola; Leonardo Salgado; Jordi Redondo
Journal of Heterocyclic Chemistry | 1989
Jordi Frigola
Journal of Heterocyclic Chemistry | 1989
Augusto Colombo; Jordi Frigola; Juan Pares; Blas Andaluz
Archive | 1987
Jordi Frigola; Augusto Colombo; Juan Pares